Evaluation of soluble CD40L measurements.

被引：0
|
作者：
Varo, N
Nuzzo, R
Libby, P
Schönbeck, U
机构：
[1] Univ Navarra Clin, Brigham & Womens Hosp, Pamplona, Spain
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CLINICAL CHEMISTRY | 2004年 / 50卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A112 / A112
页数：1
相关论文
共 50 条
  • [41] Homocysteine modulates the CD40/CD40L system
    Prontera, Cesaria
    Martelli, Nicola
    Evangelista, Virgilio
    D'Urbano, Etrusca
    Manarini, Stefano
    Recchiuti, Antonio
    Dragani, Alfredo
    Passeri, Cecilia
    Davi, Giovanni
    Romano, Mario
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (22) : 2182 - 2190
  • [42] Association between enhanced soluble CD40L and prothrombotic state in major depression
    Leo, R
    Tesauro, M
    Di Lorenzo, G
    Forleo, GB
    De Luca, L
    Lanzillo, C
    Siracusano, A
    Romeo, F
    Lauro, R
    CIRCULATION, 2004, 110 (17) : 309 - 309
  • [43] Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors
    Holler, N
    Kataoka, T
    Bodmer, JL
    Romero, P
    Romero, J
    Deperthes, D
    Engel, J
    Tschopp, J
    Schneider, P
    JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 237 (1-2) : 159 - 173
  • [44] Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles
    Michal Bereta
    Joanna Bereta
    Jonas Park
    Freddy Medina
    Heesun Kwak
    Howard L Kaufman
    Cancer Gene Therapy, 2004, 11 : 808 - 818
  • [45] Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia
    Chu, Chih-Sheng
    Lee, Kun-Tai
    Lee, Ming-Yi
    Su, Ho-Ming
    Voon, Wen-Choi
    Sheu, Sheng-Hsiung
    Lai, Wen-Ter
    ACTA CARDIOLOGICA, 2006, 61 (03) : 263 - 269
  • [46] Aspirin failure course during exercise and its connection with soluble CD40L
    Kuliczkowski, Wiktor
    Kobusiak-Prokopowicz, Malgorzata
    Prajs, Iwona
    Karolko, Bozena
    Mazurek, Walentyna
    THROMBOSIS RESEARCH, 2007, 119 (06) : 679 - 686
  • [47] Microvascular thrombosis and CD40/CD40L signaling
    Gavins, F. N. E.
    Li, G.
    Russell, J.
    Perretti, M.
    Granger, D. N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (03) : 574 - 581
  • [48] Soluble CD40L, risk of recurrent cardiac events and atorvastatin in the MIRACL study
    Kinlay, S
    Schwartz, GG
    Olsson, AG
    Rifai, N
    Sasiela, WJ
    Szarek, M
    Libby, P
    Ganz, P
    CIRCULATION, 2003, 108 (17) : 314 - 315
  • [49] Development of an Immunoassay for Quantification of Soluble Human CD40L (CD154) in Plasma Samples
    Pedersen, Kathrine
    Laursen, Nick Stub
    Hansen, Annette Gudmann
    Palarasah, Yaseelan
    Thiel, Steffen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1176 - 1176
  • [50] Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles
    Bereta, M
    Bereta, J
    Park, J
    Medina, F
    Kwak, H
    Kaufman, HL
    CANCER GENE THERAPY, 2004, 11 (12) : 808 - 818
12345